Citation Impact
Citing Papers
A Sulfilimine Bond Identified in Collagen IV
2009 StandoutScienceNobel
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Copper-free click chemistry in living animals
2010 StandoutNobel
Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition
2001
The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation.
1995
Defects in glucuronate biosynthesis disrupt Wingless signaling in Drosophila
1997
Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences.
1992
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
2000
FGF signaling in skeletal development
1998
FGF Binding and FGF Receptor Activation by Synthetic Heparan-Derived Di- and Trisaccharides
1995 Science
Expression and Biological Activity of Mouse Fibroblast Growth Factor-9
1996
Cutaneous Wound Healing
1999 Standout
Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance
1999
Multivalent Ligand-Receptor Binding Interactions in the Fibroblast Growth Factor System Produce a Cooperative Growth Factor and Heparin Mechanism for Receptor Dimerization
1994
Position, guidance, and mapping in the developing visual system
1993
Inflammation and cancer
2002 StandoutNature
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors?
1995
The FGF family: biology, pathophysiology and therapy
2009 Standout
Structural basis for fibroblast growth factor receptor activation
2005
Receptor Specificity of the Fibroblast Growth Factor Family
1996 Standout
Increased Types I and III Collagen and Transforming Growth Factor-β1 mRNA and Protein in Hypertrophic Burn Scar
1995
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
1996
Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1
2001
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Distinct Target-Derived Signals Organize Formation, Maturation, and Maintenance of Motor Nerve Terminals
2007
Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation
1994
Cancer Metastasis: Building a Framework
2006 Standout
TGF-β signalling from cell membrane to nucleus through SMAD proteins
1997 StandoutNature
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
1997 StandoutNature
Fibroblast growth factors.
2001 Standout
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
1998
Regulation of signal transduction and signal diversity by receptor oligomerization
1994
FGF22 and Its Close Relatives Are Presynaptic Organizing Molecules in the Mammalian Brain
2004
Cellular signaling by fibroblast growth factor receptors
2005 Standout
Production of cell-associated PDGF-AA by a human sarcoma cell line: evidence for a latent autocrine effect
1996
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease
2002 Standout
Analysis of the Biochemical Mechanisms for the Endocrine Actions of Fibroblast Growth Factor-23
2005
Developmental regulation of the growth plate
2003 StandoutNature
Epilysin, a Novel Human Matrix Metalloproteinase (MMP-28) Expressed in Testis and Keratinocytes and in Response to Injury
2001
Matrix Metalloproteinase-3 Releases Active Heparin-binding EGF-like Growth Factor by Cleavage at a Specific Juxtamembrane Site
1997
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
2000 Nature
Odorant Receptors Govern the Formation of a Precise Topographic Map
1998 StandoutNobel
Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes
1993
Chemical remodelling of cell surfaces in living animals
2004 StandoutNatureNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
The microenvironment of the tumour–host interface
2001 StandoutNature
Matrix metalloproteinase-7–dependent release of tumor necrosis factor-α in a model of herniated disc resorption
2000
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
1994 Standout
Matrix metalloproteinases as modulators of inflammation and innate immunity
2004 Standout
The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
1999
Signaling, Internalization, and Intracellular Activity of Fibroblast Growth Factor
2004
The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis
1999
Glypican-1 Is Frequently Overexpressed in Human Gliomas and Enhances FGF-2 Signaling in Glioma Cells
2006
FGF-19, A NOVEL FIBROBLAST GROWTH FACTOR WITH UNIQUE SPECIFICITY FOR FGFR4
1999
Klotho converts canonical FGF receptor into a specific receptor for FGF23
2006 StandoutNature
Histone acetylation in chromatin structure and transcription
1997 StandoutNature
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Fibroblast Growth Factors as Multifunctional Signaling Factors
1998
A FRET‐Based Fluorogenic Phosphine for Live‐Cell Imaging with the Staudinger Ligation
2008 StandoutNobel
The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis
1999
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
Matrix metalloproteinases in tumor–host cell communication
2002
Fibroblast Growth Factor (FGF) Homologous Factors Share Structural but Not Functional Homology with FGFs
2003
Receptor Binding and Mitogenic Properties of Mouse Fibroblast Growth Factor 3
1995
Matrix metalloproteinases: they're not just for matrix anymore!
2001
Matrix metalloproteinases: multifunctional contributors to tumor progression
2000
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Distribution of Fibroblast Growth Factor (FGF)-2 and FGF Receptor-1 Messenger RNA Expression and Protein Presence in the Mid-Trimester Human Fetus
1996
Towards a Resolution of the Stoichiometry of the Fibroblast Growth Factor (FGF)–FGF Receptor–Heparin Complex
2004
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction
1992
FGFs, heparan sulfate and FGFRs: complex interactions essential for development
2000
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Extracellular matrix remodelling and cellular differentiation
1999
Crystal Structure of a Ternary FGF-FGFR-Heparin Complex Reveals a Dual Role for Heparin in FGFR Binding and Dimerization
2000
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Dermatan Sulfate Released after Injury Is a Potent Promoter of Fibroblast Growth Factor-2 Function
1998
Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity
2000
Structural Basis for FGF Receptor Dimerization and Activation
1999
Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration
2003
Biomaterials that Regulate Growth Factor Activity via Bioinspired Interactions
2011
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
1993 StandoutNature
In Vivo Imaging of Membrane-Associated Glycans in Developing Zebrafish
2008 StandoutScienceNobel
High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains.
1994
Phenotypic consequences of lung-specific inducible expression of FGF-3
2001 StandoutNobel
The SQV-1 UDP-glucuronic acid decarboxylase and the SQV-7 nucleotide-sugar transporter may act in the Golgi apparatus to affect Caenorhabditis elegans vulval morphogenesis and embryonic development
2002 StandoutNobel
Lymphocyte Homing and Homeostasis
1996 StandoutScience
Gene Regulatory Networks and the Evolution of Animal Body Plans
2006 StandoutScience
FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development
1995
SQV-7, a protein involved in Caenorhabditis elegans epithelial invagination and early embryogenesis, transports UDP-glucuronic acid, UDP- N - acetylgalactosamine, and UDP-galactose
2001 StandoutNobel
Reduced Retinal Angiogenesis in MMP-2–Deficient Mice
2003
Making the cut: Protease-mediated regulation of angiogenesis
2006
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
2000
CXC chemokines in angiogenesis
2000
Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling
1997
Analysis of Mutations in Fibroblast Growth Factor (FGF) and a Pathogenic Mutation in FGF Receptor (FGFR) Provides Direct Evidence for the Symmetric Two-End Model for FGFR Dimerization
2005
Formation and activation by phosphorylation of activin receptor complexes.
1996
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
1992
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
The Role of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Antibody-Induced Arthritis
2002
Imaging the glycome
2008 StandoutNobel
Designing Cell-Compatible Hydrogels for Biomedical Applications
2012 StandoutScience
Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3.
1992
How Matrix Metalloproteinases Regulate Cell Behavior
2001 Standout
Insulin-like Growth Factor II Signaling in Neoplastic Proliferation Is Blocked by Transgenic Expression of the Metalloproteinase Inhibitor Timp-1
1999
Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94
2000
The Molecular Biology of Axon Guidance
1996 StandoutScience
Geometric Control of Cell Life and Death
1997 StandoutScience
Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo
2002
Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1
1994
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
2000
Chemical Glycoproteomics
2016 StandoutNobel
Works of Ehud Levi being referenced
Extracellular matrix‐resident basic fibroblast growth factor: Implication for the control of angiogenesis
1991
Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.
1992
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.
1996
Heparin Is Required for Cell-Free Binding of Basic Fibroblast Growth Factor to a Soluble Receptor and for Mitogenesis in Whole Cells
1992